Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002017751-26-000003
Filing Date
2026-03-03
Accepted
2026-03-03 20:01:48
Documents
1
Period of Report
2026-02-27

Document Format Files

Seq Description Document Type Size
1 form4-03042026_010344.html 4  
1 form4-03042026_010344.xml 4 4901
  Complete submission text file 0002017751-26-000003.txt   6434
Mailing Address 1500 BROADWAY SUITE 1401 NEW YORK NY 10036
Business Address 1500 BROADWAY SUITE 1401 NEW YORK NY 10036 332-208-6102
Nuvation Bio Inc. (Issuer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NUVATION BIO INC. 1500 BROADWAY, SUITE 1401 NEW YORK NY 10036
Business Address
Sjogren Colleen (Reporting) CIK: 0002017751 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39351 | Film No.: 26718230